USANA Health Sciences, Inc.
USANA Health Sciences, Inc. (USNA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
usna · pe ratio · data through Jan 3, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for USANA Health Sciences, Inc. (USNA) measures how much investors pay for each dollar of the company's trailing earnings. USNA's current PE ratio of 38.77x is calculated by dividing its stock price of $18.70 by its TTM earnings per share of $0.48. +97.4% elevated vs 5Y avg 19.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-01-03
PE Ratio History
2006 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%16.2x
MedianQ3 · 75%33.6x
Max
At 38.77x, USNA's current P/E is higher than in 100% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Packaged Foods · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
USANA Health Sciences, Inc.You USNA | $345M | 38.77x | +3.4% | $0.48 |
 B&G Foods, Inc. BGS | $307M | N/A | — | -$0.54 |
 BRC Inc. BRCC | $385M | N/A | — | -$0.13 |
 Calavo Growers, Inc. CVGW | $466M | 20.02x | -46.6% | $1.11 |
 Dingdong (Cayman) Limited DDL | $522M | 17.03x | -54.6% | $1.02 |
 BrasilAgro - Companhia Brasileira de Propriedades Agrícolas LND | $365M | 86.38x | +130.3% | $0.24 |
 Lifeway Foods, Inc. LWAY | $359M | 26.57x | -29.1% | $0.91 |
Industry Average 4 peers with valid PE | — | 37.50x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-01-03Latest FY2026 | 33.56x | $0.58 | +107.3% | |
2024-12-28 FY2024 | 16.19x | $2.20 | +0.1% | |
2023-12-31 FY2023 | 16.18x | $3.31 | +9.5% | |
2022-12-31 FY2022 | 14.77x | $3.60 | -15.6% | |
2021-12-31 FY2021 | 17.50x | $5.78 | +34.5% | |
2020-12-31 FY2020 | 13.01x | $5.93 | -26.5% | |
2019-12-31 FY2019 | 17.69x | $4.44 | -19.5% | |
2018-12-31 FY2018 | 21.98x | $5.36 | -22.7% | |
2017-12-31 FY2017 | 28.45x | $2.60 | +89.9% | |
2016-12-31 FY2016 | 14.98x | $4.09 | -11.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for USANA Health Sciences, Inc. (USNA) measures how much investors pay for each dollar of the company's trailing earnings. USNA's current PE ratio of 38.77x is calculated by dividing its stock price of $18.70 by its TTM earnings per share of $0.48.
Frequently asked questions
USNA pe ratio · 6 questionsUSNA's current PE ratio is 38.77x as of 2026-06-08, based on a stock price of $18.70 and TTM EPS of $0.48. Data sourced from Financial Modeling Prep via USNA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · USANA Health Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08